Cover Image
市場調查報告書

再生醫療的新時代

The New Age of Regenerative Medicine

出版商 Frost & Sullivan 商品編碼 338815
出版日期 內容資訊 英文 60 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
再生醫療的新時代 The New Age of Regenerative Medicine
出版日期: 2015年09月02日 內容資訊: 英文 60 Pages
簡介

細胞療法,是再生醫療產業中的急速成長部門。細胞療法中,包含免疫細胞療法與幹細胞療法。

本報告提供再生醫療產業調查分析、產業概要、幹細胞治療分析、上市產品、幹細胞製造和資金、共同夥伴關係等相關的系統性資訊。

摘要整理

再生醫療的新時代:概要

  • 定義
  • 市場區隔
  • 對未來的醫療保健重要的理由
  • 市場規模與成長率
  • 各地區的主要企業概要
  • 產業全體
  • 定義:細胞療法與幹細胞療法
  • 細胞療法:可利用的產品 (各種治療)
  • 競爭產品概要:各開發、主要企業
  • 可利用的初代細胞療法和同類產品
  • Cellular Dynamics International (CDI)
  • Orthofix International
  • Capricor Therapeutics
  • 大型製藥公司與再生醫療

幹細胞製造設施:市場動態

  • 幹細胞製造的市場促進因素、阻礙因素

幹細胞的消費者

  • 幹細胞的消費者資訊:美國
  • 幹細胞的消費者資訊:全球

未來趨勢

  • 未來趨勢
  • 市場機會

再生醫療產業:M&A、夥伴關係的評估

  • 全球再生醫療夥伴關係、交易
  • 主要的再生醫療夥伴關係、交易

再生醫療產業:資金方案

  • 資金方案

亞太地區的再生醫療概要

  • 市場概要
  • 主要國家
  • 主要國家的生命週期
  • 韓國
  • 中國
  • 日本
  • 新加坡
  • 主要市場進入障礙
  • 成功企業:MEDIPOST Co., Ltd.
  • 成功企業:Mesoblast Ltd.

結論

關於Frost&Sullivan

目錄
Product Code: 9AB9-00-3D-00-00

Why Stem Cell Therapy?

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.

Table of Contents

1. THE NEW AGE OF REGENERATIVE MEDICINE

Executive Summary

  • 1. Key Findings
  • 2. Key Questions This Study Will Answer
  • 3. Regenerative Medicine Industry-Where We Stand Today
  • 4. Regenerative Medicine Industry-Where We Stand Today (continued)
  • 5. Regenerative Medicine Industry-Key Stakeholders

The New Age of Regenerative Medicine-An Overview

  • 1. Definition-Regenerative Medicine
  • 2. Regenerative Medicine-Market Segmentation
  • 3. Why is Regenerative Medicine Important to the Future of Healthcare?
  • 4. Market Size and Growth-Regenerative Medicine
  • 5. Geographical Overview for Regenerative Medicine Companies
  • 6. Total Regenerative Medicine Industry
  • 7. Definitions-Cell Therapy and Stem Cell Therapy
  • 8. Cell Therapy-Commercially Available Products by Therapy
  • 9. Overview of Competing Products-By Development and Key Participants
  • 10. Commercially Available Primary Cell Therapy and Allograft Products
  • 11. Commercially Available Primary Cell Therapy and Allograft Products (continued)
  • 12. Cellular Dynamics International (CDI), Madison, Wisconsin
  • 13. Orthofix International, Lewisville, Texas
  • 14. Capricor Therapeutics, Beverly Hills, California
  • 15. Big Pharmaceuticals and Regenerative Medicine

Stem Cell Manufacturing Facilities-Market Dynamics

  • 1. Market Drivers and Restraints for Stem Cell Manufacturing

Stem Cell Consumers

  • 1. Stem Cell Consumer Information-The United States
  • 2. Stem Cell Consumer Information-Global

Future Trends

  • 1. Future Trends
  • 2. Market Opportunities

Regenerative Medicine Industry-Mergers, Acquisitions, and Partnership Assessment

  • 1. Global Partnerships and Deals for Regenerative Medicine
  • 2. Key Global Partnerships and Deals for Regenerative Medicine

Regenerative Medicine Industry-Funding Scenario

  • 1. Regenerative Medicine Market-Funding Scenario

Overview of Regenerative Medicine in Asia-Pacific

  • 1. Regenerative Medicine-Asia-Pacific Market Overview
  • 2. Regenerative Medicine-Leading APAC Countries
  • 3. Regenerative Medicine-Leading APAC Countries(continued)
  • 4. Regenerative Medicine-Lifecycle for Leading APAC Countries
  • 5. Regenerative Medicine-South Korea
  • 6. Regenerative Medicine-China
  • 7. Regenerative Medicine-Japan
  • 8. Regenerative Medicine-Singapore
  • 9. Regenerative Medicine-Key Market Access Barriers
  • 10. Successful Stem Cell Therapy Company-MEDIPOST Co., Ltd.
  • 11. Successful Stem Cell Therapy Company-Mesoblast Ltd.

Conclusion

  • 1. The Last Word
  • 2. Legal Disclaimer

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top